The effect of short-chain fatty acids on human monocyte-derived dendritic cells by Nastasi, Claudia et al.
1Scientific RepoRts | 5:16148 | DOi: 10.1038/srep16148
www.nature.com/scientificreports
The effect of short-chain fatty 
acids on human monocyte-derived 
dendritic cells
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Patrizia Brigidi2, Niels Ødum1, Thomas Litman4 & Anders Woetmann1
The gut microbiota is essential for human health and plays an important role in the pathogenesis 
of several diseases. Short-chain fatty acids (SCFA), such as acetate, butyrate and propionate, are 
end-products of microbial fermentation of macronutrients that distribute systemically via the 
blood. The aim of this study was to investigate the transcriptional response of immature and LPS-
matured human monocyte-derived DC to SCFA. Our data revealed distinct effects exerted by each 
individual SCFA on gene expression in human monocyte-derived DC, especially in the mature ones. 
Acetate only exerted negligible effects, while both butyrate and propionate strongly modulated 
gene expression in both immature and mature human monocyte-derived DC. An Ingenuity pathway 
analysis based on the differentially expressed genes suggested that propionate and butyrate 
modulate leukocyte trafficking, as SCFA strongly reduced the release of several pro-inflammatory 
chemokines including CCL3, CCL4, CCL5, CXCL9, CXCL10, and CXCL11. Additionally, butyrate and 
propionate inhibited the expression of lipopolysaccharide (LPS)-induced cytokines such as IL-6 and IL-
12p40 showing a strong anti-inflammatory effect. This work illustrates that bacterial metabolites far 
from the site of their production can differentially modulate the inflammatory response and generally 
provides new insights into host-microbiome interactions.
The gut microbiota is essential for several aspects of human health and is involved in the pathogenesis 
or as protection factor for several human diseases, such as obesity, inflammatory bowel disease, type 1–2 
diabetes, atopic disease, acute graft-versus host disease1–4. Recent studies highlight the profound effect of 
fiber-rich diet on the metabolism and composition of the gut microbiota, with profound feedback con-
sequences on the host immunological pathways5,6. However, most of the mechanisms of host-microbiota 
interactions remain obscure. Dietary fibers have been linked with a lower risk of death from a range of 
conditions, including cardiovascular disease, infections and cancers7. It seems clear that making fiber-rich 
food choices more often may provide significant health benefits but, however, little is known about the 
mechanisms. Dietary fibers are complex carbohydrates that can be fermented by fibrolythic components 
of the gut microbiota, generating physiologically active metabolites. Short-chain fatty acids (SCFA), such 
as acetate, butyrate and propionate, are among the most abundant of these dietary metabolites released 
in the proximal colon at high concentrations (70–140 mM) while lower concentrations are found in the 
distal colon (20–70 mM) and in the distal ileum (20–40 mM). The molar ratio of acetate, propionate, 
and butyrate production in the colon is approximately 60:25:15, respectively, but it varies depending on 
diet, site of fermentation, and microbiota composition8,9. Notably, SCFA are not restricted to the intes-
tinal lumen but are readily absorbed by colonocytes, released into the bloodstream and then reach the 
liver through the portal vein. From here SCFA are then released systematically to the peripheral venous 
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system at even lower concentrations10. Experiments carried out on mice models allowed dissection of the 
multifactorial role of these metabolites on the host immunological phenotype. SCFA have been shown 
to modulate several cell signaling pathways in immune cells11–13, indicating that intestinal microbiota 
shape the immune system through their metabolites, and hence that SCFA are key mediators for the 
host-microbe mutualism. Indeed, the exacerbated inflammatory reactions observed in germ-free mouse 
models of disease are likely to relate in part to the absence of SCFA in the gut, blood, or tissues14,15. SCFA 
exert their effects through G-protein-coupled receptors (GPCRs). The major GPCRs activated by SCFA 
are GPR43 (FFAR2) and GPR41 (FFAR3), and GPR109A (HCAR2) for both murine and human immune 
cells16–21. However, the expression pattern of SCFA receptors in human DC has been poorly investigated, 
although expression of GPR41 and GPR43 mRNA in human DC has been described16,18.
DC are professional antigen-presenting cells within the immune system and once activated they play 
a pivotal role in attracting and priming T-cells. Recently, propionate was shown to affect mouse dendritic 
cells (DC) and macrophage biology in the bone marrow and affect T helper 2 (Th2) cell responses in the 
airway22 confirming the important role of SCFA on the mouse immune system. However, little is known 
about the effect of SCFA on human DC. The experimental use of human primary DC is limited by their 
scarcity in peripheral blood (< 1% of peripheral blood mononuclear cells (PBMC)), so to circumvent 
this, monocyte-derived DC in vitro are commonly employed as a pragmatic model23,24.
The aim of this study was to investigate the gene transcription modulation by Affymetrix GeneChip 
and potential pathways in human immature and mature human monocyte-derived DC after exposure to 
acetate, butyrate, or propionate. The results revealed distinct transcriptional responses elicited by these 
bacterial metabolites indicating that butyrate and propionate exerts important immunomodulatory roles 
by down-regulating genes involved in inflammation and immune cell trafficking.
Results
SCFA receptor expression by human monocyte-derived DC. To determine the expression pat-
tern of SCFA receptors on human monocyte-derived DC, we performed qPCR assays for the main SCFA 
receptors genes such as GPR43, GPR41, and GPR109A. MCF-7 cells were used as positive control as they 
Figure 1. Expression of SCFA receptors by human monocyte-derived DC and primary CD141 + and 
CD1c + DC. (a) qPCR for SCFAs receptors on monocyte-derived DC compared to MCF-7 cell line as 
internal control. Shown are the averages ± standard deviations (SD) (n = 3). (b) Flow cytometry analysis 
of GPR41 and GPR109A surface expression on monocyte-derived DC and (c) primary CD141 + and 
CD1c + DC. Mean fluorescence intensity (MFI) averages ± standard deviations (SD) (n = 3) are reported 
below each histogram. Gates for GPR41- or GPR190A-positive cells in both figures (b,c) has been placed 
according to their respective isotype control. The different shades of grey represent cells from three different 
donors used for the experiments.
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have previously been reported to express both GPR43 and GPR4125. As shown in Fig. 1a we found that 
human monocyte-derived DC expresses GPR43 and GPR41 mRNA at lower and higher level, respec-
tively, compared to the positive control cell line MCF-7. In addition, we observed very high expression 
levels of GPR109A mRNA in human monocyte-derived DC. Furthermore, we investigated the surface 
expression of GPR41 and GPR109A on human monocyte-derived DC by flow cytometry. As shown in 
Fig. 1b, we used cells from three different donors, (each donor represented by different shades of grey), to 
confirm that both receptors are expressed, albeit we observed that surface proteins expression of GPR41 
was higher than GPR109A.
Furthermore, we examined the expression of SCFA receptors on primary human CD1c+ and 
CD141 + DC by flow cytometry. We found that both subsets of DC express GPR41 and GPR109 on 
the surface of cells from three different donors (Fig. 1c, each donor represented by a different shade of 
grey). Taken together, this indicates that human monocyte-derived DC, like primary human CD1c+ and 
CD141+ DC, has the ability to respond to SCFA through GPR41 and GPR109A.
DC exposure to SCFA and impact on maturation markers. Monocytes isolated from three dif-
ferent healthy donors were used to generate both im-DC and m-DC.
Then im-DC were treated with 1 mM (physiological concentration) of sodium acetate (im-DC_A), 
sodium butyrate (im-DC_B), or sodium propionate (im-DC_P) for the last 24 h of culture. In parallel, 
in order to explore how SCFA modulates the lipopolysaccharide (LPS) -induced maturation of human 
monocyte-derived DC, we exposed im-DC to the LPS, at the same time of the SCFA addition. So, after 
24 h, we obtained the following groups of treatment named: m-DC_A, m-DC_B, and m-DC_P.
Im-DC SCFA-untreated (im-DC) and m-DC SCFA-untreated (m-DC) were used as controls for the 
immature and mature state, respectively. Treatment with 1 mM of each SCFA did not change the per-
centage of apoptotic cells (untreated monocyte-derived DC 1.4%, acetate 1.1%, propionate 1.0%, and 
butyrate 1.8% respectively).
In order to validate the DC’s maturation stage flow cytometry analysis was performed with particular 
attention to the surface expression of maturation markers such as HLA-DR, CD83 and CD8624,26,27. As 
expected, their expression upon the membrane was increased after the addition of LPS to the culturing 
media (Fig. 2a). Next we investigate the impact of SCFA on human monocyte-derived DC maturation 
makers. Interestingly, the presence of SCFA did not affect the expression of either HLA-DR or CD86, 
whereas the LPS-induced expression of CD83 was significantly reduced by the exposure to both propi-
onate and butyrate when compared to normally matured DC (Fig. 2b,c).
Figure 2. (a) Flow cytometry DC gating and SCFA effect. The figure is representative of the gating strategy 
for DC for HLA-DR, CD83, and CD86 markers for both monocyte-derived im-DC and m-DC. (b) A 
representative example of SCFA effect on im-DC and m-DC expression of CD86 and CD83 markers by 
flow cytometry. (c) Effect of SCFA on DC maturation markers. Numbers calculated represented by flow 
cytometry indicate the mean fluorescence intensity (MFI) of each sample. Shown are the averages ± 
standard deviations (SD) (n = 3); Mann-Whitney U t-test, *P < 0.05.
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SCFA effect on immature and mature DC. Comparing untreated im-DC to untreated m-DC 
revealed 1752 differentially expressed genes (DEG) (cut off criteria: > 2-fold change, p < 0.05) emerged 
by Affymetrix GeneChip. Exposure to SCFA resulted in significant modulation of the m-DC gene expres-
sion but only in a moderate effect on the im-DC gene expression (Fig. 3a).
Visualization of the samples by principal component analysis (PCA) further supported the specific 
and stronger effect of butyrate and propionate on the m-DC. The same behavior was observed for im-DC, 
with an overall lower variation in the expression profile. In contrast, the effect of acetate treatment is sim-
ilar to the one shown by untreated controls (both for im-DC and m-DC) (Fig. 3b). Indeed, the transcrip-
tome analysis revealed that butyrate and propionate, more than acetate, elicit a specific response by both 
treated im-DC, and m-DC; the general effect exerted by SCFA can be ranked as: acetate < propionate < 
butyrate. Acetate only induced minor changes in gene expression (8 DEG) in im-DC, and none in m-DC.
Further, acetate seems not to share many affected genes with either butyrate (none and 4, up- and 
down-regulated genes, respectively) or propionate (1 and 0, respectively) in immature DC. Further, 
acetate has no effect on mature DC not sharing any DEG in common with butyrate and propionate. 
Propionate affects few genes (13 up-, and 9 down- regulated) while butyrate shows the biggest effect—
up-regulating 177 and down-regulating 159 genes—on im-DC. Furthermore, butyrate and propionate 
share 230 up- and 41 down-regulated genes in m-DC and, again, butyrate exerts an even more profound 
effect on m-DC, up- and down-regulating 458 and 321 genes, respectively (Fig. 3c).
Ingenuity pathway analysis (IPA) based on DEGs identified no significant networks or pathways 
involved by acetate treatment emphasizing the effect exerted by butyrate and propionate. In fact, IPA 
analysis revealed “granulocyte adhesion and diapedesis” as one of the top canonical pathways following 
exposure to butyrate, for both im-DC and m-DC; similar findings apply to the effect of propionate, albeit 
only on m-DC. Indeed among the down-regulated genes are found several chemokines that have been 
affected by butyrate and propionate, especially in the mature stage of DC (Table 1). The top molecules 
down-regulated in the m-DC cells after butyrate treatment when compared to the untreated control 
are CXCL9 (log2-fold change) (− 5.4), CXCL10 (− 5.1), CXCL11 (− 5.3), CCL19 (− 4.0) and the top 
molecules that are down-regulated by propionate treatment includes CXCL9 (− 2.0), CCL19 (− 1.7), 
IL-6 (− 2.1), IL12B (− 1.8) (S1) indicating an overall immunomodulatory effect exerted by both of these 
SCFA. Among the genes up-regulated by butyrate in both im-DC and m-DC we noticed ALDH1A1 
Figure 3. (a) Heat-map and unsupervised hierarchical clustering based on the top 200 differentially 
expressed genes (DEG). (b) Principal component analysis (PCA) sample plot based on the 737 most 
variable genes across experiments. Primary clustering is seen according to im-/m-dendritic cells (DC). The 
samples are colored according to treatment with either acetate (a), propionate (P), or butyrate (b). Each dot 
represents one pooled sample from three donors. (c) Venn diagrams showing the number of overlapping up-
(red) and down-(green) regulated genes by im-DC and m-DC after exposure to A (acetate), P (propionate), 
or B (butyrate).
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(aldehyde dehydrogenase 1 family, member 1), that codes for an enzyme involved in metabolizing reti-
noic acid and that exerts an immunomodulatory role in mice28.
Immunomodulatory effects of butyrate and propionate on m-DC. The transcriptome analy-
sis revealed that butyrate and propionate exert a strong immunomodulatory effect on mature DC. For 
LPS-treated DC the butyrate effect is most pronounced in normalizing the gene expression levels back to 
those observed in the PBS-treated DC down-regulating the CXCL9, CXCL10, CXCL11, and IL12B genes. 
The propionate effect is similar albeit weaker than butyrate and also decreases the expression of CXCL9, 
IL6 and IL12B. To confirm the microarray data we performed qPCR for IL6 and IL12B in parallel with 
ELISA assays for secreted IL-6 and IL12p40 (IL12B) protein. Both butyrate and propionate significantly 
reduced LPS-induced IL6 mRNA expression (P < 0.05, Fig. 4a), whereas the effect on IL12B gene expres-
sion was significant (P < 0.05) only after butyrate treatment but not for propionate, as shown in Fig. 4b. 
The effect on LPS-induced IL-6 was confirmed by ELISA for IL-6 release by mature DC exposed to 
butyrate and propionate as protein levels were significantly reduced (P < 0.05, respectively) (Fig. 4c). The 
effect of SCFA on LPS-induced production of IL-12p40 by human monocyte derived DC was likewise 
confirmed by ELISA. As shown in Fig. 4d, both propionate and butyrate significantly reduced the level 
of secreted IL-12p40 protein (P < 0.05, respectively).
Furthermore, we measured the chemokines secreted into the media through LEGENDPlex™ array 
confirming a significant reduction of CXCL9, CXCL10, and CXCL11 production after butyrate and pro-
pionate exposure by m-DC (Fig. 5a).
Comparison Top canonical pathway Top diseases and bio functions Top networks
m-DCs vs. im-DCs Dendritic cell maturation Immunological diseases
Cellular Movement, Hematological 
System Development and Function, 
Immune Cell Trafficking
imDCs_A vs. im-DC No effect
imDC_B vs. im-DC
Granulocyte adhesion and 
diapedesis; agranulocyte adhesion 
and diapedesis
Inflammatory response
Antigen Presentation, Lipid 
Metabolism, Small Molecule 
Biochemistry
imDCs_P vs. im-DCs Eicosanoid signaling
Inflammatory response; 
hematological system 
development and function; cell-
to-cell signaling and interaction
Cardiovascular Disease, 
Inflammatory Response, Cell-To-
Cell Signaling and Interaction
mDCs_A vs. mDCs no effect
mDCs_B vs. mDCs
Granulocyte adhesion and 
diapedesis; role of Pattern 
Recognition Receptors in 
Recognition of Bacteria and Viruses; 
dendritic cell maturation
Cell movement; Cellular function 
and maintenance; hematological 
system development and function
DNA Replication, Recombination, 
and Repair, Nucleic Acid 
Metabolism, Small Molecule 
Biochemistry
mDCs_P vs. mDCs
Granulocyte adhesion and 




cell-to-cell signaling and 
interaction; hematological system 
development and function
Cellular Function and 
Maintenance, Cellular 
Development, Hematological 
System Development and Function
mDCs_B vs. mDC_A
Granulocyte adhesion and 
diapedesis; role of Pattern 
Recognition Receptors in 
Recognition of Bacteria and Viruses; 
dendritic cell maturation
Inflammatory response; Cellular 
function and maintenance; 
hematological system 
development and function




Granulocyte adhesion and 
diapedesis; dendritic cell maturation; 
Communication between Innate and 
Adaptive Immune Cells
Immunological disease; 
Cell-to-cell signaling and 
interaction; immune cell 
trafficking; hematological system 
development
Cell-To-Cell Signaling and 
Interaction, Hematological System 
Development and Function, 
Immune Cell Trafficking
mDCs_P vs. mDC_B
Granulocyte adhesion and 
diapedesis; agranulocyte adhesion 
and diapedesis
Immunological disease; 
Cell-to-cell signaling and 
interaction; hematological system 
development
Antimicrobial Response, 
Inflammatory Response, Infectious 
Disease
Table 1. IPA analysis report. The table shows the top canonical pathways, diseases and bio-functions 
and networks involved after SCFA exposure. Supplement 1. The top DEG according to each experimental 
condition. Column annotation: Gene symbol: The official gene symbol according to HUGO nomenclature. 
im-DC: Log2(AFU) in im-DC. m/im: The log2-ratio between m-DC and im-DC. A: The log2-ratio between 
acetate-treated im-DC and control im-DC. P: The log2-ratio between propionate-treated im-DC and control 
im-DC. B: The log2-ratio between butyrate-treated im-DC and control im-DC. Am: The log2-ratio between 
acetate-treated m-DC and control m-DC. Pm: The log2-ratio between propionate-treated m-DC and control 
m-DC. Bm: The log2-ratio between butyrate-treated m-DC and control m-DC. B/Pm: The log2-ratio 
between butyrate-treated m-DC and propionate-treated m-DC.
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In order to further investigate the effect of SCFA on DC chemokine patterns we measured ten 
chemokines by LEGENDPlex™ array. This analysis revealed that im-DC are not responsive to the addi-
tion of SCFA in contrast to mature DC whose chemokine production changes specifically depending 
on what SCFA is added into the media. As mentioned above, butyrate and propionate, but not acetate, 
significantly reduce the secretion of CXCL9, − 10, − 11 by m-DC (Fig. 5a). Further, CCL3 release is sig-
nificantly reduced by acetate and propionate, but not by butyrate; CCL4 is reduced only by butyrate but 
not by acetate neither by propionate; CCL5 production decreases after butyrate and propionate exposure 
but is not modified by acetate (Fig. 5b). CCL2, CCL11, CXCL11 are not significantly affected by SCFA 
and CXCL5 is not produced at all by m-DC (Fig. 5c).
Discussion
Human beings have been recently reconsidered as super-organisms in co-evolution with an immense 
microbial community living in the gastrointestinal tract that is essential for the development, education 
and functionality of our immune system29. Dendritic cells behave as sentinels of the immune system and 
their function is to sample antigen in inflamed tissue and migrate to the local lymph nodes where the 
DC besides the presentation of these antigens to T naive cells also produce cytokines, thus influencing 
the polarization into different T-helper-cell subsets e.g. Th1, Th2 or Th17. In this study we hypothesized 
that SCFA, secreted into the gut and distributed through blood to tissues, have immunomodulatory 
effects on human dendritic cells that, as APCs, have the ability to shape the immune system’s response.
Immune cells, including DC, use specific receptors to sense and respond to bacterial metabolites. 
According to the literature, one largely used mechanism is via metabolite-sensing GPCRs such as, 
GPR43, GPR41, and GPR109A, all of which can act as receptors, with different specificity and affinity, 
for SCFA16,18,20,21,30. Indeed, many of the actions related to SCFA, and linked to gut homeostasis, have 
been ascribed to GPR43 and GPR109A that are both expressed by inflammatory leukocytes (such as 
neutrophils and macrophages) and by T regulatory cells (Tregs)13,28. Recently, GPR109A has emerged as 
a major regulator of gut immune homeostasis28 binding not only the SCFA butyrate but also the trypto-
phan metabolite nicotinic acid, whose anti-inflammatory properties are well known31,32. However, SCFA 
Figure 4. IL6 and IL12B qPCR ((a,b) respectively) and IL-6 and IL-21p40 ELISA ((c,d) respectively) 
on monocyte-derived m-DC and im-DC treated with acetate, propionate, and butyrate. Shown are the 
averages ± standard deviations (SD) (n = 3); Mann-Whitney U t-test p values: *P ≤ 0.05; **P ≤ 0.01.
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effects are not restricted to GPR43 and GPR109A, given that a recent study established a role for propi-
onate and the SCFA receptor GPR41 in the generation of macrophage and DC precursors22. As shown 
in Fig. 1a, we observed that GPR41 and GPR109A are both expressed by human monocyte-derived DC, 
whereas GPR43 is only weakly expressed. Surface expression of GPR41 and GPR109A was confirmed by 
flow cytometry (Fig. 1b), indicating that both these receptors may be important for the SCFA induced 
signal transduction.
We also examined the expression of GPR41 and GPR109A on human primary CD1c+ and CD141+ 
DC by flow cytometry, and found the both subset of cells express the receptors on the surface, indicating 
that primary human DC has the ability to respond to SCFA comparable to human monocyte-derived 
DC.
The transcriptomic analysis revealed that butyrate and propionate, more than acetate, elicit a specific 
response by human DC. Furthermore, butyrate and propionate share the largest number of affected 
host dendritic cell genes. This is supported by Lukovac et al., who reported a similar trend in the effect 
of propionate and butyrate on epithelia cells in a in vitro murine gut organoid model33. In particular, 
among these observations we focused on the potential immunomodulatory effect exerted by SCFA on 
the lipopolysaccharide (LPS) -induced maturation of human monocyte-derived DC, previously reported 
on another type of APC cells such as bone marrow-derived macrophages in a murine model12. It is 
known that macrophages, once activated by LPS, have the important role to prime and enhance the 
inflammasome producing large amounts of CCL2, TNF-α , IL-12p40 and IL-6. Additionally, it has been 
shown that mainly butyrate suppresses the production of those inflammatory mediators by monocytes 
and macrophages16,34 and that it seems to enhance the release of the anti-inflammatory cytokine IL-1035. 
In accord with these results, we observed that among the SCFA analyzed, butyrate and propionate play 
a crucial role in modulating immune responses in human mature dendritic cells. In particular, in our 
study, propionate shows the ability to significantly reduce IL-6 expression and protein release, as well 
as butyrate. In addition, both butyrate and propionate reduced the LPS-induced gene expression and 
protein production of IL-12B (IL12p40), a shared component of both IL-12 and IL-23 formation36. This 
latter data lead us to hypothesize that both SCFA, compromising the IL-12 and IL-23 production, could 
shape the naïve T-cell polarization by reducing the pro-inflammatory Th1 and Th17 phenotypes and 
therefore shifting the balance towards anti-inflammatory populations such as Tregs, as already shown 
in mice11. In addition, it also appears that the activity of butyrate and propionate is selective because 
these SCFA affect primary LPS response genes such as TNF-α family genes and CCL2, while other LPS 
Figure 5. Chemokine patterns by im-DC and m-DC treated with acetate, propionate, and butyrate. 
Shown are the averages ± standard deviations (SD) (n = 3); Unpaired t test with Welch’s correction, 
*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
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response genes such as HLA-DR, CD86, IL-1A, IL-1B, are unaffected or even up-regulated (Fig. 2c and 
Supplementary 1).
Another aspect of our study was to explore how the DC chemokine pattern was influenced by SCFA 
taken that the chemokine production is instrumental for DC to regulate the recruitment of different cell 
types for both the afferent and efferent limb of the immune response37. In addition to their chemotactic 
effect on neutrophils, it is known that SCFA also modulate production and release of chemokines and 
expression of adhesion molecules in neutrophils and endothelial cells38,39, which may be relevant to their 
effect on leukocyte recruitment. We observed that in the first 24h after exposure to SCFA each of them 
showed a distinctive effect; acetate reduces the release of CCL3, butyrate decreases CCL4, CCL5 and 
CXCL9, − 10, − 11 and propionate CCL3, CCL5 and CXCL9, − 10, − 11, both in terms of gene expres-
sion and protein production. Previously, Sallusto et al. showed that inflammatory chemokines, such as 
CCL3, CCL4, and CCL5, can be induced during maturation/activation of human monocyte-derived 
DC37 and, together with the other pro-inflammatory chemokines CXCL9, CXCL10, CXCL11, our results 
strongly support the notion that SCFA exert an immunomodulatory effect per se directly on DC. It is 
likely that inflammatory chemokines regulate cell traffic within secondary lymphoid tissues and, thus, it 
may influence T cell development during antigen recognition40. Our data clarify that among the three 
SCFA studied, butyrate and propionate exert the main immunomodulatory role directly influencing the 
gene expression profile of DC. These findings open a new perspective about the SCFA ability to shape 
the inflammatory response through DC, regulating leukocyte polarization and recruitment.
Materials and Methods
Human monocyte-derived DC generation and culture. DC was generated from peripheral blood 
mononuclear cells (PBMC) isolated from buffy coats obtained from anonymous healthy blood donors 
(n = 3). Written informed consent was obtained from blood donors at the Department of Clinical 
Immunology, University Hospital Rigshospitalet, Copenhagen and used without the possibility to identify 
case specific information. The ethical committee, Region H, The Capital Region of Denmark, approved 
the use of these buffy coats for research. The research was carried out in accordance with the approved 
guidelines. The mononuclear cells were separated by Ficoll-Hypaque density gradient centrifugation and 
subsequently CD14+ monocytes were isolated from PBMCs by positive selection using magnetic beads 
(Miltenyi Biotec, Germany), according to the manufacturer’s instructions. Monocytes were cultured at 
37 °C in 5% CO2 in media supplemented with 10% fetal bovine serum (FBS, Gibco) GM-CSF and IL-4 
(50 ng/ml both, PeproTech) for 7 days to generate im-DC and m-DC, after LPS (100 ng/ml, E.coli 055:B5, 
Sigma-Aldrich) stimulation for the last 24h.
Human primary CD141+ and CD1C+ analysis. PBMCs were isolated from buffy coats (n = 3) as 
described above and primary dendritic cells CD141+ and CD1C+ were analyzed by flow cytometry in 
triplicate.
SCFA treatments. Before SCFA treatment was performed, a 7-AAD (Sigma-Aldrich) assay was 
applied to determine the SCFA concentration that does not affect DC viability. Based on the 7-AAD 
assay, 1mM was chosen for each SCFA treatment as representative of human gut physiologic concentra-
tion. For both im-DC and m-DC the last 24h were used for the single exposure to acetate, propionate 
or butyrate (Sigma-Aldrich).
7-Aminoactinomycin apoptosis assay. Cells were stained with 7-aminoactinomycin, and subjected 
to flow cytometry analysis as described elsewhere41.
Flow cytometry analysis. Cell staining was performed by LSR Fortessa (BD) at the CFFC (Core 
Facility for Flow Cytometry, Faculty of Health and Medical Sciences, University of Copenhagen). 
Anti-human HLA-DR (PE, BD, clone L243), anti-human CD83 (BV421, Biolegend, clone HB15e) 
and anti-human CD86 (APC, Biolegend, clone IT2.2), anti-human CD141 (BV421, BD, clone 1A4), 
anti-human CD1c (BB515, BD, clone F10/21A3), anti-human GPR41 (APC, LSBio), anti-human 
GPR109A (APC, R&D), and all the respective isotypes were used (all purchased by BD or R&D). FACS 
data were analyzed by FlowJo v7.0.
LEGENDPlex and ELISA arrays. IL-6 and IL-12p40 production was measured in the supernatants of 
DC by ELISA using R&D kits. For simultaneous quantification of chemokines we applied the bead-based 
multiplex assay LEGENDPlex (BioLegend) and analyzed by LSRFortessa (BD) at the CFFC.
RNA isolation and expression profiling. RNA was isolated and purified using the RNA was iso-
lated and purified using the RNeasy kit (Quiagen) according to the manufacturer’s instructions, then 
quantified using a spectrophotometer (NanoDrop, Wilmington, DE). Equal amounts of RNA derived 
from the three donors were pooled, each treatment with its own corresponding control. Sample labeling 
and microarray hybridization were performed according to the manufacturer’s instructions (Affymetrix).
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Global gene expression analysis was conducted using Affymetrix GeneChip® Human Transcriptome 
Array HTA 2.0 covering > 285.000 full-length transcripts (performed by AROS Applied Biotechnology 
A/S, Aarhus, DK). The array data were normalized using Robust Multichip Average (RMA) normaliza-
tion as recommended by Bolstad et al.42. Significance of DEG (2-fold change, p < 0.05) was assessed by 
ANOVA, and adjusted for multiple testing by estimating false discovery rates (FDR). Data visualization, 
including principal component analysis (PCA), heat maps and clustering was performed in Qlucore 
Omics Explorer v.3.0 (Qlucore AB, Lund, Sweden). Functional analysis and network representation of 
DEG was performed in Ingenuity Pathway Analysis (IPA, Ingenuity® Systems).
Real-time PCR. Total RNA was isolated using RNeasy Mini Kit (Qiagen) and cDNA was transcribed 
using the High Capacity cDNA Reverse Transcription Kit followed by PCR analysis using TaqMan® 
Gene Expression Assay method. All TaqMan probes were purchased from LifeTechnologies (GAPDH 
(Hs02758991_g1), GPR43 (Hs00271142_s1), GPR41 (Hs02519193_g1), GPR109A (Hs02341584_s1), IL6 
(Hs00985639_m1), IL12B (Hs01011518_m1). Amplification was performed in an Mx3000P real-time 
thermal cycler (Stratagene) on standard settings. Data presented here was obtained from three independ-
ent experiments. Each experiment included three technical replicates. Results are presented as relative 
quantity to the control sample determined by the ddCt method, using GAPDH as reference gene and 
untreated im-DC as calibrator.
Microarray data accession number. Raw microarray data have been deposited in the GEO database 
(http://www.ncbi.nlm.nih.gov/geo/) under accession no. GSE66989.
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